Valuation: Amoéba

Market Cap 4.78Cr 5.52Cr 4.48Cr 4.09Cr 7.68Cr 526.29Cr 7.8Cr 53Cr 21Cr 263.52Cr 21Cr 20Cr 878.7Cr P/E 2026 *
-9.25x
P/E 2027 * 69.4x
Enterprise Value 5.9Cr 6.8Cr 5.52Cr 5.04Cr 9.47Cr 649.03Cr 9.62Cr 65Cr 25Cr 324.98Cr 26Cr 25Cr 1.08TCr EV / Sales 2026 *
11.6x
EV / Sales 2027 * 3.84x
Free-Float
87.09%
Yield 2026 *
-
Yield 2027 * -
1 week-3.96%
Current month-3.16%
1 month-6.75%
3 months-21.69%
6 months-20.00%
Current year-25.89%
1 week 0.66
Extreme 0.662
0.74
1 month 0.62
Extreme 0.616
0.76
3 years 0.34
Extreme 0.3415
1.34
5 years 0.34
Extreme 0.3415
1.75
Manager TitleAgeSince
Chief Executive Officer 60 14/12/2023
Chief Tech/Sci/R&D Officer - 01/09/2018
Corporate Officer/Principal - 01/03/2022
Director TitleAgeSince
Director/Board Member - 01/06/2014
Chairman 70 14/12/2023
Director/Board Member 70 25/05/2023
Change 5-day change 1-year change 3-year change Capi.($)
+2.03%-3.96%-14.15%+17.73% 5.52Cr
-0.13%-2.42%-16.88%-24.41% 321.74Cr
+0.37%+0.64%+8.33%-1.80% 218.74Cr
+1.11%+2.05%-20.61%-34.18% 182.04Cr
-0.28%-2.94%+17.76%+2.90% 168.43Cr
+2.41%+3.73%-22.15% - 155.95Cr
-0.59%-2.40%-16.23%-47.17% 137.28Cr
+0.22%-0.76%-26.12%+35.97% 133.71Cr
-1.30%-3.77%-9.35%-18.10% 125.68Cr
-0.69%+4.16%-29.63%+80.05% 110.43Cr
Average +0.12%-1.02%-12.90%+1.22% 172.66Cr
Weighted average by Cap. +0.18%-0.90%-11.59%-6.40%

Financials

2026 *2027 *
Net sales 51L 58.86L 47.78L 43.58L 81.94L 56Cr 83.2L 5.62Cr 2.2Cr 28Cr 2.21Cr 2.16Cr 94Cr 1.56Cr 1.79Cr 1.46Cr 1.33Cr 2.5Cr 171.18Cr 2.54Cr 17Cr 6.7Cr 86Cr 6.74Cr 6.59Cr 285.81Cr
Net income -52L -60.02L -48.72L -44.44L -83.55L -57Cr -84.83L -5.73Cr -2.24Cr -29Cr -2.25Cr -2.2Cr -96Cr 6L 6L 5L 5L 9L 6.05Cr 9L 60.61L 23.69L 3.03Cr 23.83L 23.32L 10Cr
Net Debt 1.12Cr 1.29Cr 1.04Cr 95.29L 1.79Cr 122.75Cr 1.82Cr 12Cr 4.8Cr 61Cr 4.83Cr 4.73Cr 204.94Cr 1.18Cr 1.37Cr 1.11Cr 1.01Cr 1.9Cr 130.45Cr 1.93Cr 13Cr 5.1Cr 65Cr 5.14Cr 5.02Cr 217.81Cr
Logo Amoéba
Amoéba is a greentech company whose ambition is to become a major player in the treatment of microbiological risk based on the patented use of amoebae in the plant protection and cosmetics sectors. With know-how that is unique in the world and protected by numerous patents, Amoéba is currently the only company capable of exploiting the full potential of the Willaertia amoeba on an industrial scale and cultivating it in sufficient volumes to offer biological solutions that constitute a viable alternative to the chemical products widely used today. Amoéba is currently focusing on the global biocontrol market for plant protection and on the cosmetics market.
Employees
-
Date Price Change
12/26/12 €0.7040 +2.03%
11/26/11 €0.6900 -0.29%
10/26/10 €0.6920 -6.74%
07/26/07 €0.7420 +2.63%
06/26/06 €0.7230 -1.36%
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
0.6940EUR
Average target price
1.400EUR
Spread / Average Target
+101.73%

Annual profits - Rate of surprise